The number of shares and votes in Tobii AB has increased by 20,438 as a result of exercise of warrants in accordance with the company's incentive programs.
Today, the last trading day of the month, there are in total 98,925,103 shares and votes in the company. After the increase, the share capital amounts to SEK 717,892.89. The increase in the number of shares is due to the exercise of warrants in accordance with the Company's incentive programs.
This information is information that Tobii is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out below, on December 28, 2018, at 16.00 p.m. CET.
CONTACT:
Sara Hyléen, VP of Corporate Communications & Investor Relations, Tobii AB, phone: +46-709-16-16-41, email: [email protected]
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ? Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...
